Apr 7, 2022, 01:00 AM by User Not Found

Bio-IT World | There was no escaping last week’s announcement that the final 8% of the human genome—the equivalent of an entire DNA chromosome—has been sequenced, filling a gap left nearly 20 years after the Human Genome Project declared victory. More than 100 researchers from around the world collaborated on the initiative and many of them, and the institutions they represent, have weighed in on the feat.

Apr 5, 2022, 01:00 AM by User Not Found

Bio-IT World | Penn State researchers have created synthetic “prediction markets” for speculating on the replicability of published studies with unparalleled accuracy. When betting on published social and behavioral science papers, about 90% of the time bot agents correctly “bought” papers that were eventually reproduced.

Mar 31, 2022, 01:00 AM by User Not Found

Bio-IT World | Funds raised for life science company investment, AI-powered single-cell analysis, spatial biology, ML-based discovery of new anti-infectives, and real-time supply chain operations analysis.

Mar 30, 2022, 01:00 AM by User Not Found

Bio-IT World | A genomic network model is used to identify aurora kinase inhibitor-sensitive lung tumors, new Illumina Accelerator start-ups are announced, AI algorithms are being used to improve prostate cancer identification and treatment, and a blood-based DNA methylation test can detect liver cancer

Mar 29, 2022, 09:00 AM by User Not Found

Bio-IT World | Jim Bilotta found his home in orphan diseases early in his career, driven by both personal experience and the “unbelievable” impact on patients and their families. Today, as Chief Information Officer, head of IT, at Alnylam, he is still pursuing that impact. In the latest episode of Bio-IT World’s Trends from the Trenches podcast, Bilotta and Trends from the Trenches host, Stan Gloss, discuss digital transformation at Alnylam, and how Bilotta views the distinction between digitization and digital transformation.

Mar 28, 2022, 01:00 AM by User Not Found

Bio-IT World | As the biopharmaceutical industry begins to embrace advanced data collection and analysis tools, it finds itself facing a challenging question: How can drug manufacturers best harness all that data to improve capacity, reduce bottlenecks and cut costs? Establishing a strong digital backbone is the first critical step. From there, manufacturers need to figure out how to strengthen this digital backbone with technology that not only makes the data easily accessible, but also empowers manufacturers to analyze it and use it to make transformative predictions.

Mar 25, 2022, 13:59 PM by User Not Found

Bio-IT World | A future where single-chain nanobodies and biologically active proteins might voyage through the blood-brain barrier to treat neurological conditions—including Alzheimer’s disease and brain tumors—recently came closer into view with the discovery of an antibody that succeeded in temporarily opening and resealing the crucial filtering mechanism in mice.

Mar 23, 2022, 15:40 PM by User Not Found

Bio-IT World | Leonid Peshkin, Ph.D., is an unconventional man working at an Ivy League research university in a field he believes is rightfully viewed with “great skepticism” by mainstream biologists. The war on aging he is advancing puts to the test both interventions designed to extend healthspan (the period of life where one is healthy) and our understanding how the ravages of time get undone in the germline, an approach he likens to a Russian “Koschei” fairy tale where the secret to eternal health is in the egg.

Mar 18, 2022, 01:00 AM by User Not Found

Bio-IT World | Nearly 100,000 highly diverse whole genome sequences are now available through the National Institutes of Health's All of Us Research Program, the NIH announced today. About 50% of the data is from individuals who identify with racial or ethnic groups that have historically been underrepresented in research. This data will enable researchers to address yet unanswerable questions about health and disease, leading to new breakthroughs and advancing discoveries to reduce persistent health disparities.

Mar 17, 2022, 12:27 PM by

Mar 17, 2022, 12:27 PM by

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Mar 17, 2022, 12:27 PM by

Creative Peptides announces the release of innovative peptide drug discovery services to support and assist global clients in winning the race of peptide drug development.

Mar 17, 2022, 12:27 PM by

Creative Peptides rolls out a variety of PNA FISH probe products with high sensitivity and specific hybridization for worldwide customers.

Mar 17, 2022, 12:27 PM by

Creative Peptides provides useful approaches for labeling peptides with fluorescent dyes

Mar 17, 2022, 12:27 PM by

Lyniate and NextGate have entered into a merger agreement.

Mar 17, 2022, 12:27 PM by

ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHOTM Transient Expression System.

Mar 17, 2022, 12:27 PM by

Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal March 14, 2022 - North Carolina-based Triangle Business Journal recently unveiled the winners of its 2022 class of Health Care Leadership Awards, naming Rho as one of this year’s honorees. The global, full-service contract research organization (CRO) was chosen from a pool of Triangle-area nominees that work in a number of health care settings, including major hospital systems, small physician groups, life sciences firms and nonprofit health charities. "The honorees of this year’s Health Care Leadership Awards are making a significant impact on the quality of health care in the Triangle region," said Jason Christie, market president and publisher of TBJ. "This year’s honorees really are heroes in our community. Triangle Business Journal is pleased to honor them.”

Mar 17, 2022, 12:27 PM by

Mar 17, 2022, 12:27 PM by

Decentralized Clinical Trial Platform Provider Welcomes 100th Teammate

Mar 17, 2022, 12:27 PM by

Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities